Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Antibiotic therapy after acute myocardial infarction: a prospective randomized study.

Zahn R, Schneider S, Frilling B, Seidl K, Tebbe U, Weber M, Gottwik M, Altmann E, Seidel F, Rox J, Höffler U, Neuhaus KL, Senges J; Working Group of Leading Hospital Cardiologists.

Circulation. 2003 Mar 11;107(9):1253-9.

2.

Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.

Leowattana W, Bhuripanyo K, Singhaviranon L, Akaniroj S, Mahanonda N, Samranthin M, Pokum S.

J Med Assoc Thai. 2001 Dec;84 Suppl 3:S669-75.

PMID:
12002908
3.
4.

Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.

Burkhardt U, Zahn R, Höffler U, Siegler KE, Frilling B, Weber M, Gottwik M, Wehr M, Seidel F, Rosocha S, Tebbe U, Senges J.

Z Kardiol. 2004 Sep;93(9):671-8.

PMID:
15365734
6.

Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.

Sander D, Winbeck K, Klingelhöfer J, Etgen T, Conrad B.

Circulation. 2004 Mar 2;109(8):1010-5. Epub 2004 Feb 9.

7.

Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study.

Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B.

Eur Heart J. 1999 Jan;20(2):121-7.

PMID:
10099908
9.

Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome.

Sinisalo J, Mattila K, Valtonen V, Anttonen O, Juvonen J, Melin J, Vuorinen-Markkola H, Nieminen MS; Clarithromycin in Acute Coronary Syndrome Patients in Finland (CLARIFY) Study Group.

Circulation. 2002 Apr 2;105(13):1555-60.

10.

Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance.

Neumann FJ.

Circulation. 2002 Nov 5;106(19):2414-6. No abstract available.

11.

Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events.

Berg HF, Maraha B, Scheffer GJ, Quarles-van Ufford M, Vandenbroucke-Grauls CM, Peeters MF, Kluytmans JA.

Clin Infect Dis. 2005 Feb 1;40(3):358-65. Epub 2005 Jan 6.

PMID:
15668857
12.

Antibiotics against Chlamydia pneumoniae and prognosis after acute myocardial infarction.

Pilote L, Green L, Joseph L, Richard H, Eisenberg MJ.

Am Heart J. 2002 Feb;143(2):294-300.

PMID:
11835034
13.

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.

Muhlestein JB, Anderson JL, Carlquist JF, Salunkhe K, Horne BD, Pearson RR, Bunch TJ, Allen A, Trehan S, Nielson C.

Circulation. 2000 Oct 10;102(15):1755-60.

14.

Chlamydia pneumoniae eradication from carotid plaques. Results of an open, randomised treatment study.

Melissano G, Blasi F, Esposito G, Tarsia P, Dordoni L, Arosio C, Tshomba Y, Fagetti L, Allegra L, Chiesa R.

Eur J Vasc Endovasc Surg. 1999 Oct;18(4):355-9.

15.

Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.

Vainas T, Stassen FR, Schurink GW, Tordoir JH, Welten RJ, van den Akker LH, Kurvers HA, Bruggeman CA, Kitslaar PJ.

Eur J Vasc Endovasc Surg. 2005 Apr;29(4):403-11.

16.

Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.

Berrocal DH, Cohen MG, Spinetta AD, Ben MG, Rojas Matas CA, Gabay JM, Magni JM, Nogareda G, Oberti P, Von Schulz C, Doval H, Bazzino OO, Cagide A, Oliveri R, Grinfeld LR.

Am Heart J. 2003 Dec;146(6):E22.

PMID:
14661011
18.

[Antibodies against Chlamydophila in patients with acute myocardial infarction and coronary risk and their association with mortality].

García-Elorriaga G, Sánchez-Barriga JJ, Ramos-Corrales MA, González-Bonilla C.

Salud Publica Mex. 2005 May-Jun;47(3):227-33. Spanish.

PMID:
16104465
19.

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.

Neumann F, Kastrati A, Miethke T, Pogatsa-Murray G, Mehilli J, Valina C, Jogethaei N, da Costa CP, Wagner H, Schömig A.

Lancet. 2001 Jun 30;357(9274):2085-9.

PMID:
11445102
20.

Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial.

Hopstaken RM, Nelemans P, Stobberingh EE, Muris JW, Rinkens PE, Dinant GJ.

J Fam Pract. 2002 Apr;51(4):329-36.

PMID:
11978255

Supplemental Content

Support Center